IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q2 2025 Holdings

Filed 2025-08-14 | 11 holdings | $305.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vanguard Intl Equity Index F(VEU)ALLWRLD EX US922042775$144.0M2,142,68447.1%
Ishares TR(INDA)MSCI INDIA ETF46429B598$135.0M2,425,14444.2%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$10.0M989,4103.3%
Foghorn Therapeutics Inc(FHTX)COM344174107$7.4M1,573,7612.4%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$2.8M2,627,6430.9%
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$2.5M4,1040.8%
Alector Inc(ALEC)COM014442107$1.8M1,307,8580.6%
Surrozen Inc(SRZN)COM NEW86889P208$784.0K87,6960.3%
Rapt Therapeutics Inc(RAPT)COM NEW75382E208$657.9K82,2340.2%
Tenaya Therapeutics Inc(TNYA)COM87990A106$620.8K1,015,7050.2%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$3.1K170,8330.0%